Source:http://linkedlifedata.com/resource/pubmed/id/16284704
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-2-23
|
pubmed:abstractText |
A new fluorescent analog of D -glucose was recently developed by [Yoshioka K, Takahashi H, Homma T, Sato M, Ki Bong O, Nemoto Y, Matsuoka H (1996) A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim Biophys Acta 1289:5-9] and shown to be transported into normal cells. The purpose of this preliminary study was to assess the use of this fluorescent 2-deoxyglucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG), as a sensitive probe for monitoring glucose uptake into malignant tumor cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1536-1632
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
388-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16284704-4-Chloro-7-nitrobenzofurazan,
pubmed-meshheading:16284704-Biological Transport,
pubmed-meshheading:16284704-Cell Line,
pubmed-meshheading:16284704-Cell Line, Tumor,
pubmed-meshheading:16284704-Deoxyglucose,
pubmed-meshheading:16284704-Humans,
pubmed-meshheading:16284704-Neoplasms
|
pubmed:articleTitle |
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
|
pubmed:affiliation |
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, 6431 Fannin, Houston, TX 77030, USA. roger.g.oneil@uth.tmc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|